Page last updated: 2024-08-22

methylprednisolone hemisuccinate and Focal Segmental Glomerulosclerosis

methylprednisolone hemisuccinate has been researched along with Focal Segmental Glomerulosclerosis in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gluck, C; Hooper, DK; Koziell, A; Moodalbail, D; Okamura, D; Shah, L; Wallace, D; Zaritsky, JJ1

Other Studies

1 other study(ies) available for methylprednisolone hemisuccinate and Focal Segmental Glomerulosclerosis

ArticleYear
LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients.
    Pediatric nephrology (Berlin, Germany), 2019, Volume: 34, Issue:11

    Topics: Allografts; Blood Component Removal; Child; Child, Preschool; Combined Modality Therapy; Creatinine; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Humans; Infant; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Transplantation; Lipoproteins, LDL; Male; Methylprednisolone Hemisuccinate; Proteinuria; Pulse Therapy, Drug; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome

2019